Latest News and Press Releases
Want to stay updated on the latest news?
-
LUND, Sweden, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Active Biotech (NASDAQ OMX NORDIC: ACTI) is scheduled to present at the Jefferies Global Healthcare Conference held November 20-21, 2013 in London, UK....
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Lund den 14 november 2013 - Active Biotech...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Lund, Sweden, November 14, 2013 - Active...
-
LUND, Sweden, Nov. 11, 2013 (GLOBE NEWSWIRE) -- In accordance with a decision made by the Annual General Meeting held on May 15, 2013, the Election Committee shall comprise the...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Enligt beslut från årsstämman den 15 maj 2013,...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} In accordance with a decision made by the Annual...
-
LUND, Sweden, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Laquinimod * Analysis of data from the Phase III ALLEGRO study shows that laquinimod provides a beneficial impact on brain tissue damage;...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Laquinimod Analys av data från fas...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Laquinimod Analysis of data from the Phase...
-
LUND, Sweden, Nov. 4, 2013 (GLOBE NEWSWIRE) -- Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that its partner Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will initiate a ...